- Home
- NTRP vs TENX Comparison
NTRP vs TENX Comparison
Compare NTRP & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRP
- TENX
- Stock Information
- Founded
- NTRP 1985
- TENX 1967
- Country
- NTRP United States
- TENX United States
- Employees
- NTRP N/A
- TENX N/A
- Industry
- NTRP
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- NTRP
- TENX Health Care
- Exchange
- NTRP NYSE
- TENX Nasdaq
- Market Cap
- NTRP 24.8M
- TENX 21.6M
- IPO Year
- NTRP N/A
- TENX N/A
- Fundamental
- Price
- NTRP $2.36
- TENX $5.73
- Analyst Decision
- NTRP Hold
- TENX Strong Buy
- Analyst Count
- NTRP 1
- TENX 3
- Target Price
- NTRP $5.00
- TENX $16.00
- AVG Volume (30 Days)
- NTRP 53.5K
- TENX 18.4K
- Earning Date
- NTRP 05-06-2025
- TENX 05-13-2025
- Dividend Yield
- NTRP N/A
- TENX N/A
- EPS Growth
- NTRP N/A
- TENX N/A
- EPS
- NTRP N/A
- TENX N/A
- Revenue
- NTRP $623,664.00
- TENX N/A
- Revenue This Year
- NTRP $354.28
- TENX N/A
- Revenue Next Year
- NTRP $536.37
- TENX N/A
- P/E Ratio
- NTRP N/A
- TENX N/A
- Revenue Growth
- NTRP 186.93
- TENX N/A
- 52 Week Low
- NTRP $1.39
- TENX $2.77
- 52 Week High
- NTRP $8.50
- TENX $7.89
- Technical
- Relative Strength Index (RSI)
- NTRP 31.39
- TENX 42.57
- Support Level
- NTRP $2.41
- TENX $4.63
- Resistance Level
- NTRP $3.28
- TENX $5.75
- Average True Range (ATR)
- NTRP 0.77
- TENX 0.42
- MACD
- NTRP -0.24
- TENX -0.04
- Stochastic Oscillator
- NTRP 8.20
- TENX 47.70
About NTRP NEXTTRIP INC
NextTrip Inc is a technology-driven platform delivering travel booking and travel media solutions. It provides individual and group travelers with vacations to popular and sought-after destinations in Mexico, the Caribbean, and across the world. NextTrip Media platform - Travel Magazine offers a social media platform for viewers to explore, educate, and share with friends their bucket list travel. The company is also launching an end-to-end content ecosystem that uses AI-assisted travel planning capturing advertising, building brand awareness, rewarding loyalty, and driving bookings.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.